The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental Signatures
Open accessAbstract
Diffuse large B-cell lymphoma (DLBCL) is a biologically and clinically heterogeneous disease. Transcriptomic and genetic characterization of DLBCL has increased the understanding of its intrinsic pathogenesis and provided potential therapeutic targets. However, the role of the microenvironment in DLBCL biology remains less understood. Here, we performed a transcriptomic analysis of the microenvironment of 4,655 DLBCLs from multiple independent cohorts and described four major lymphoma microenvironment categories that associate with distinct biological aberrations and clinical behavior. We also found evidence of genetic and epigenetic mechanisms deployed by cancer cells to evade microenvironmental constraints of lymphoma growth, supporting the rationale for implementing DNA hypomethylating agents in selected patients with DLBCL. In addition, our work uncovered new therapeutic vulnerabilities in the biochemical composition of the extracellular matrix that were exploited to decrease DLBCL proliferation in preclinical models. This novel classification provides a road map for the biological characterization and therapeutic exploitation of the DLBCL microenvironment. Significance: In a translational relevant transcriptomic-based classification, we characterized the microenvironment as a critical component of the B-cell lymphoma biology and associated it with the DLBCL clinical behavior establishing a novel opportunity for targeting therapies. This article is highlighted in the In This Issue feature, p. 1307
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Fast unfolding of communities in large networks
Blondel, V. D., Guillaume, J.-L., Lambiotte, R., & Lefebvre, E. (2008) · Journal of Statistical Mechanics: Theory and Experiment · doi:10.1088/1742-5468/2008/10/p10008 · Cited by 21,424
GSVA: gene set variation analysis for microarray and RNA-Seq data
Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
Salmon provides fast and bias-aware quantification of transcript expression
Patro, R., Duggal, G., Love, M. I., Irizarry, R. A., & Kingsford, C. (2017) · Nature Methods · doi:10.1038/nmeth.4197 · Cited by 12,700
NCBI GEO: archive for functional genomics data sets—update
Barrett, T., Wilhite, S. E., Ledoux, P., Evangelista, C., Kim, I. F., Tomashevsky, M., Marshall, K. A., Phillippy, K. H., Sherman, P. M., Holko, M., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1193 · Cited by 10,418
Near-optimal probabilistic RNA-seq quantification
Bray, N. L., Pimentel, H., Melsted, P., & Pachter, L. (2016) · Nature Biotechnology · doi:10.1038/nbt.3519 · Cited by 9,723
QuPath: Open source software for digital pathology image analysis
Bankhead, P., Loughrey, M. B., Fernández, J. A., Dombrowski, Y., McArt, D. G., Dunne, P. D., McQuaid, S., Gray, R. T., Murray, L. J., Coleman, H. G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17204-5 · Cited by 8,908
Trapnell, C., Cacchiarelli, D., Grimsby, J., Pokharel, P., Li, S., Morse, M., Lennon, N. J., Livak, K. J., Mikkelsen, T. S., & Rinn, J. L. (2014) · Nature Biotechnology · doi:10.1038/nbt.2859 · Cited by 7,314
DNA methylation age of human tissues and cell types
Horvath, S. (2013) · Genome Biology · doi:10.1186/gb-2013-14-10-r115 · Cited by 7,075
Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications
Krueger, F., & Andrews, S. R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr167 · Cited by 5,297
Reversed graph embedding resolves complex single-cell trajectories
Qiu, X., Mao, Q., Tang, Y., Wang, L., Chawla, R., Pliner, H. A., & Trapnell, C. (2017) · Nature Methods · doi:10.1038/nmeth.4402 · Cited by 5,070
Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
Molecular and genetic properties of tumors associated with local immune cytolytic activity
Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G., & Hacohen, N. (2015) · Cell · doi:10.1016/j.cell.2014.12.033 · Cited by 3,825
Becht, E., Giraldo, N. A., Lacroix, L., Buttard, B., Elarouci, N., Petitprez, F., Selves, J., Laurent-Puig, P., Sautès-Fridman, C., Fridman, W. H., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-1070-5 · Cited by 3,685
Leinonen, R., Sugawara, H., Shumway, M., & on behalf of the International Nucleotide Sequence Database Collaboration (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1019 · Cited by 2,746
Zerbino, D. R., Achuthan, P., Akanni, W., Amode, M. R., Barrell, D., Bhai, J., Billis, K., Cummins, C., Gall, A., Girón, C. G., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1098 · Cited by 2,605
DELLY: structural variant discovery by integrated paired-end and split-read analysis
Rausch, T., Zichner, T., Schlattl, A., Stütz, A. M., Benes, V., & Korbel, J. O. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts378 · Cited by 2,459
Genetics and pathogenesis of diffuse large B-cell lymphoma
Schmitz, R., Wright, G. W., Huang, D. W., Johnson, C. A., Phelan, J. D., Wang, J. Q., Roulland, S., Kasbekar, M., Young, R. M., Shaffer, A. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1801445 · Cited by 2,241
Self-citationmethylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles
Akalin, A., Kormaksson, M., Li, S., Garrett-Bakelman, F. E., Figueroa, M. E., Melnick, A., & Mason, C. E. (2012) · Genome Biology · doi:10.1186/gb-2012-13-10-r87 · Cited by 2,238
Self-citationChapuy, B., Stewart, C., Dunford, A. J., Kim, J., Kamburov, A., Redd, R. A., Lawrence, M. S., Roemer, M. G. M., Li, A. J., Ziepert, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0016-8 · Cited by 1,941
Stromal Gene Signatures in Large-B-Cell Lymphomas
Lenz, G., Wright, G., Dave, S. S., Xiao, W., Powell, J., Zhao, H., Xu, W., Tan, B., Goldschmidt, N., Iqbal, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802885 · Cited by 1,808
Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data
Racle, J., de Jonge, K., Baumgaertner, P., Speiser, D. E., & Gfeller, D. (2017) · eLife · doi:10.7554/elife.26476 · Cited by 1,384
Toil enables reproducible, open source, big biomedical data analyses
Vivian, J., Rao, A. A., Nothaft, F. A., Ketchum, C., Armstrong, J., Novak, A., Pfeil, J., Narkizian, J., Deran, A. D., Musselman-Brown, A., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3772 · Cited by 1,365
Wright, G. W., Huang, D. W., Phelan, J. D., Coulibaly, Z. A., Roulland, S., Young, R. M., Wang, J. Q., Schmitz, R., Morin, R. D., Tang, J., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.015 · Cited by 1,169
Self-citationPerturbation-response genes reveal signaling footprints in cancer gene expression
(2017) · doi:10.1038/s41467-017-02391-6 · Cited by 1,108
Genetic and functional drivers of diffuse large B cell lymphoma
Reddy, A., Zhang, J., Davis, N. S., Moffitt, A. B., Love, C. L., Waldrop, A., Leppa, S., Pasanen, A., Meriranta, L., Karjalainen-Lindsberg, M.-L., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.027 · Cited by 1,104
Wright, G., Tan, B., Rosenwald, A., Hurt, E. H., Wiestner, A., & Staudt, L. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732008100 · Cited by 1,040
An Immune Atlas of Clear Cell Renal Cell Carcinoma
Chevrier, S., Levine, J. H., Zanotelli, V. R. T., Silina, K., Schulz, D., Bacac, M., Ries, C. H., Ailles, L., Jewett, M. A. S., Moch, H., et al. (2017) · Cell · doi:10.1016/j.cell.2017.04.016 · Cited by 1,004
DeRose, Y. S., Wang, G., Lin, Y.-C., Bernard, P. S., Buys, S. S., Ebbert, M. T. W., Factor, R., Matsen, C., Milash, B. A., Nelson, E., et al. (2011) · Nature Medicine · doi:10.1038/nm.2454 · Cited by 1,002
Germinal-Center Organization and Cellular Dynamics
Allen, C. D. C., Okada, T., & Cyster, J. G. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.009 · Cited by 983
Smyth, M. J., Dunn, G. P., & Schreiber, R. D. (2006) · Advances in Immunology · doi:10.1016/s0065-2776(06)90001-7 · Cited by 870
Monti, S. (2005) · Blood · doi:10.1182/blood-2004-07-2947 · Cited by 820
Fiori, M. E., Di Franco, S., Villanova, L., Bianca, P., Stassi, G., & De Maria, R. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0994-2 · Cited by 647
A genome-wide transcriptomic analysis of protein-coding genes in human blood cells
Uhlen, M., Karlsson, M. J., Zhong, W., Tebani, A., Pou, C., Mikes, J., Lakshmikanth, T., Forsström, B., Edfors, F., Odeberg, J., et al. (2019) · Science · doi:10.1126/science.aax9198 · Cited by 594
Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival
Johnson, N. A., Savage, K. J., Ludkovski, O., Ben-Neriah, S., Woods, R., Steidl, C., Dyer, M. J. S., Siebert, R., Kuruvilla, J., Klasa, R., et al. (2009) · Blood · doi:10.1182/blood-2009-03-212191 · Cited by 587
AnnotSV: an integrated tool for structural variations annotation
Geoffroy, V., Herenger, Y., Kress, A., Stoetzel, C., Piton, A., Dollfus, H., & Muller, J. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty304 · Cited by 473
Ennishi, D., Jiang, A., Boyle, M., Collinge, B., Grande, B. M., Ben-Neriah, S., Rushton, C., Tang, J., Thomas, N., Slack, G. W., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01583 · Cited by 414
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)
Younes, A., Hilden, P., Coiffier, B., Hagenbeek, A., Salles, G., Wilson, W., Seymour, J. F., Kelly, K., Gribben, J., Pfreunschuh, M., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx097 · Cited by 369
Self-citationCancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy
Vesely, M. D., & Schreiber, R. D. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12105 · Cited by 367 · cited 1×
“4i), potentially representing lymphoma cells that may 304 be able to escape tumor immunity(28,29).”
BackgroundTGF-beta in CAF-mediated tumor growth and metastasis
Calon, A., Tauriello, D. V. F., & Batlle, E. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.12.008 · Cited by 342
Antigen receptor repertoire profiling from RNA-seq data
Bolotin, D. A., Poslavsky, S., Davydov, A. N., Frenkel, F. E., Fanchi, L., Zolotareva, O. I., Hemmers, S., Putintseva, E. V., Obraztsova, A. S., Shugay, M., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3979 · Cited by 333
Self-citationEnnishi, D., Takata, K., Béguelin, W., Duns, G., Mottok, A., Farinha, P., Bashashati, A., Saberi, S., Boyle, M., Meissner, B., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1090 · Cited by 318 · cited 2×
“In turn, lymphoma cells develop and/or select genetic and epigenetic traits that contribute to the evasion of immune microenvironmental constraints (19).”
BackgroundNeill, T., Schaefer, L., & Iozzo, R. V. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.04.029 · Cited by 304
Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma
Muppidi, J. R., Schmitz, R., Green, J. A., Xiao, W., Larsen, A. B., Braun, S. E., An, J., Xu, Y., Rosenwald, A., Ott, G., et al. (2014) · Nature · doi:10.1038/nature13765 · Cited by 295
Distinct microbial and immune niches of the human colon
James, K. R., Gomes, T., Elmentaite, R., Kumar, N., Gulliver, E. L., King, H. W., Stares, M. D., Bareham, B. R., Ferdinand, J. R., Petrova, V. N., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0602-z · Cited by 294
Nie, M., Yang, L., Bi, X., Wang, Y., Sun, P., Yang, H., Liu, P., Li, Z., Xia, Y., & Jiang, W. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1226 · Cited by 250
B-Cell Receptor Signaling in Diffuse Large B-Cell lymphoma
Young, R. M., Shaffer, A. L., Phelan, J. D., & Staudt, L. M. (2015) · Seminars in Hematology · doi:10.1053/j.seminhematol.2015.01.008 · Cited by 222
Mechanism-Based Epigenetic Chemosensitization Therapy of Diffuse Large B-Cell Lymphoma
Clozel, T., Yang, S., Elstrom, R. L., Tam, W., Martin, P., Kormaksson, M., Banerjee, S., Vasanthakumar, A., Culjkovic, B., Scott, D. W., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0117 · Cited by 222
Self-citationMonti, S., Chapuy, B., Takeyama, K., Rodig, S. J., Hao, Y., Yeda, K. T., Inguilizian, H., Mermel, C., Currie, T., Dogan, A., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.07.014 · Cited by 207
Gupta, M., Han, J. J., Stenson, M., Maurer, M., Wellik, L., Hu, G., Ziesmer, S., Dogan, A., & Witzig, T. E. (2012) · Blood · doi:10.1182/blood-2011-10-388538 · Cited by 194
The Genetic Landscape of Diffuse Large B-Cell Lymphoma
Pasqualucci, L., & Dalla-Favera, R. (2015) · Seminars in Hematology · doi:10.1053/j.seminhematol.2015.01.005 · Cited by 178
Azzaoui, I., Uhel, F., Rossille, D., Pangault, C., Dulong, J., Le Priol, J., Lamy, T., Houot, R., Le Gouill, S., Cartron, G., et al. (2016) · Blood · doi:10.1182/blood-2015-08-662783 · Cited by 168
Tissue matrix arrays for high-throughput screening and systems analysis of cell function
Beachley, V. Z., Wolf, M. T., Sadtler, K., Manda, S. S., Jacobs, H., Blatchley, M. R., Bader, J. S., Pandey, A., Pardoll, D., & Elisseeff, J. H. (2015) · Nature Methods · doi:10.1038/nmeth.3619 · Cited by 164
Xu-Monette, Z. Y., Xiao, M., Au, Q., Padmanabhan, R., Xu, B., Hoe, N., Rodríguez-Perales, S., Torres-Ruiz, R., Manyam, G. C., Visco, C., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0439 · Cited by 164
Naba, A., Clauser, K. R., & Hynes, R. O. (2015) · Journal of Visualized Experiments · doi:10.3791/53057 · Cited by 153
Tumor microenvironment (TME)-driven immune suppression in B cell malignancy
Nicholas, N. S., Apollonio, B., & Ramsay, A. G. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.11.003 · Cited by 143
Small Leucine Rich Proteoglycans (decorin, biglycan and lumican) in cancer
Appunni, S., Anand, V., Khandelwal, M., Gupta, N., Rubens, M., & Sharma, A. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.01.003 · Cited by 132
de Charette, M., & Houot, R. (2018) · Haematologica · doi:10.3324/haematol.2017.184192 · Cited by 129
Ciavarella, S., Vegliante, M. C., Fabbri, M., Summa, S. D., Melle, F., Motta, G., Iuliis, V. D., Opinto, G., Enjuanes, A., Rega, S., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy450 · Cited by 129
The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome
Duran‐Ferrer, M., Clot, G., Nadeu, F., Beekman, R., Baumann, T., Nordlund, J., Marincevic-Zuniga, Y., Lönnerholm, G., Rivas‐Delgado, A., Martín, S., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-00131-2 · Cited by 114
Garrett-Bakelman, F. E., Sheridan, C. K., Kacmarczyk, T. J., Ishii, J. K., Betel, D., Alonso, A., Mason, C. E., Figueroa, M. E., & Melnick, A. M. (2015) · Journal of Visualized Experiments · doi:10.3791/52246 · Cited by 109
Self-citationIL-4/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma
Pandey, S., Mourcin, F., Marchand, T., Nayar, S., Guirriec, M., Pangault, C., Monvoisin, C., Amé-Thomas, P., Guilloton, F., Dulong, J., et al. (2017) · Blood · doi:10.1182/blood-2016-08-737239 · Cited by 101
Cayrol, F., Flaqué, M. C. D., Fernando, T. M., Yang, S. N., Sterle, H., Bolontrade, M. F., Amorós, M., Issé, B. A., Farías, R. N., Ahn, H., et al. (2014) · Blood · doi:10.1182/blood-2014-07-587337 · Cited by 100
Self-citationLi, L., Zhang, J., Chen, J., Xu-Monette, Z. Y., Miao, Y., Xiao, M., Young, K. H., Wang, S., Medeiros, L. J., Wang, M. L., et al. (2018) · Blood · doi:10.1182/blood-2018-03-841015 · Cited by 100
Conpair: concordance and contamination estimator for matched tumor–normal pairs
Bergmann, E. A., Chen, B., Arora, K. S., Vacic, V., & Zody, M. C. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw389 · Cited by 95
A modular transcriptome map of mature B cell lymphomas
Loeffler‐Wirth, H., Kreuz, M., Hopp, L., Arakelyan, A., Haake, A., Cogliatti, S., Feller, A. C., Hansmann, M., Lenze, D., Mӧller, P., et al. (2019) · Genome Medicine · doi:10.1186/s13073-019-0637-7 · Cited by 89
IL10 receptor is a novel therapeutic target in DLBCLs
Béguelin, W., Sawh, S., Chambwe, N., Chan, F. C., Jiang, Y., Choo, J.-W., Scott, D. W., Chalmers, A. J., Geng, H., Tsikitas, L., et al. (2015) · Leukemia · doi:10.1038/leu.2015.57 · Cited by 86
Manfroi, B., McKee, T., Mayol, J. F., Tabruyn, S. P., Moret, S., VILLIERS, C. L., Righini, C. A., Dyer, M. J. S., Callanan, M. B., Schneider, P., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0786 · Cited by 85
Evens, A. M., Sehn, L. H., Farinha, P., Nelson, B. P., Raji, A. A., Lu, Y., Brakman, A., Parimi, V., Winter, J. N., Schumacker, P. T., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.1893 · Cited by 84
Stromal Cell Contribution to Human Follicular Lymphoma Pathogenesis
Mourcin, F., Pangault, C., Amin-Ali, R., Amé-Thomas, P., & Tarte, K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00280 · Cited by 67
Feist, M., Schwarzfischer, P., Heinrich, P., Sun, X., Kemper, J., von Bonin, F., Pérez-Rubio, P., Taruttis, F., Rehberg, T., Dettmer, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03803-x · Cited by 59
Kant, S., Kumar, A., & Singh, S. M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.09.020 · Cited by 56
Liu, X.-Q., Lu, K., Feng, L., Ding, M., Gao, J., Ge, X., & Wang, X. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.804917 · Cited by 45
Haro, M., & Oršulić, S. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00098 · Cited by 35
Stelling, A., Wu, C. T., Bertram, K., Hashwah, H., Theocharides, A. P. A., Manz, M. G., Tzankov, A., & Mueller, A. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000210 · Cited by 25
Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells
Subbarayan, K., Leisz, S., Wickenhauser, C., Bethmann, D., Massa, C., Steven, A., & Seliger, B. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1373233 · Cited by 24
Frontzek, F., & Lenz, G. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1683447 · Cited by 17
Marullo, R., Rutherford, S. C., Leonard, J. P., & Cerchietti, L. C. A. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1207839 · Cited by 9
Self-citation
Cited by
The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma
Steen, C. B., Luca, B. A., Esfahani, M. S., Azizi, A., Sworder, B. J., Nabet, B. Y., Kurtz, D. M., Liu, C. L., Khameneh, F., Advani, R. H., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.08.011 · Cited by 332
Metadata
- Authors
- Kotlov, N., Bagaev, A., Revuelta, M. V., Phillip, J. M., Cacciapuoti, M. T., Antysheva, Z., Svekolkin, V., Tikhonova, E., Miheecheva, N., Kuzkina, N., Nos, G., Tabbo, F., Frenkel, F., Ghione, P., Tsiper, M., Almog, N., Fowler, N., Melnick, A. M., Leonard, J. P., Inghirami, G., & Cerchietti, L.
- Venue
- Cancer Discovery
- Published
- 2021-02-04
- Volume
- 11
- Issue
- 6
- Pages
- 1468-1489
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- OpenAlex
- W3128501672
- Cited by
- 267
- References
- 80
- FWCI
- 23.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.